C1OO34 Stock Overview
Develops, manufactures, and markets contact lens wearers. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
The Cooper Companies, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$58.98 |
52 Week High | US$61.92 |
52 Week Low | US$41.36 |
Beta | 0.99 |
11 Month Change | -4.75% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -1.08% |
5 Year Change | n/a |
Change since IPO | 57.81% |
Recent News & Updates
Recent updates
Shareholder Returns
C1OO34 | BR Medical Equipment | BR Market | |
---|---|---|---|
7D | -2.6% | -1.6% | -0.1% |
1Y | n/a | 16.4% | -1.3% |
Return vs Industry: Insufficient data to determine how C1OO34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how C1OO34 performed against the BR Market.
Price Volatility
C1OO34 volatility | |
---|---|
C1OO34 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.1% |
Market Average Movement | 4.5% |
10% most volatile stocks in BR Market | 8.5% |
10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: C1OO34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine C1OO34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies, Inc. Fundamentals Summary
C1OO34 fundamental statistics | |
---|---|
Market cap | R$115.00b |
Earnings (TTM) | R$2.08b |
Revenue (TTM) | R$22.05b |
55.2x
P/E Ratio5.2x
P/S RatioIs C1OO34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
C1OO34 income statement (TTM) | |
---|---|
Revenue | US$3.80b |
Cost of Revenue | US$1.28b |
Gross Profit | US$2.52b |
Other Expenses | US$2.17b |
Earnings | US$359.30m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Dec 05, 2024
Earnings per share (EPS) | 1.80 |
Gross Margin | 66.36% |
Net Profit Margin | 9.45% |
Debt/Equity Ratio | 33.2% |
How did C1OO34 perform over the long term?
See historical performance and comparison